Main > TERRORISM > BioTerrorism. > Bacillus anthracis > Infection. Treatment. > Ciprofloxacin > Non-Generic. Production

Product USA. B

CAPACITY Tripling production to make 200 million tablets in next 3 months by running its plants continuously & reopening another plant
COMMENTS Pres & CEO says Co is committed to working with U.S. government to help the need for ciprofloxacin
CLASSIFICATION CommPat Market
ECONOMY Co. also says it will keep prices at pre-Sept 11 levels
STATUS Co. which holds the patent on ciprofloxacin until 12.03
UPDATE 10.01
CONTACT This data is not available for free
MARKETING BY This data is not available for free
PATENT ASSIGNEE This data is not available for free
PRODUCTION BY This data is not available for free
TRADEMARK This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back